Antitumor activity of photodynamic therapy performed with nanospheres containing zinc-phthalocyanine

Abstract

BackgroundThe increasing incidence of cancer and the search for more effective therapies with minimal collateral effects have prompted studies to find alternative new treatments. Among these, photodynamic therapy (PDT) has been proposed as a very promising new modality in cancer treatment with the lowest rates of side effects, revealing itself to be particularly successful when the photosensitizer is associated with nanoscaled carriers. This study aimed to design and develop a new formulation based on albumin nanospheres containing zinc-phthalocyanine tetrasulfonate (ZnPcS4-AN) for use in the PDT protocol and to investigate its antitumor activity in Swiss albino mice using the Ehrlich solid tumor as an experimental model for breast cancer.MethodsEhrlich tumor’s volume, histopathology and morphometry were used to assess the efficacy of intratumoral injection of ZnPcS4-AN in containing tumor aggressiveness and promoting its regression, while the toxicity of possible treatments was assessed by animal weight, morphological analysis of the liver and kidneys, hemogram, and serum levels of total bilirubin, direct bilirubin, indirect bilirubin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma glutamyl transferase (GGT), alkaline phosphatase, creatinine and urea. In order to evaluate the efficacy of PDT, groups of animals treated with intratumoral injection of doxorubicin (Dox) were also investigated.ResultsIntratumoral injection of ZnPcS4-AN was found to be efficient in mediating PDT to refrain tumor aggressiveness and to induce its regression. Although tumor volume reduction was not significant, PDT induced a remarkable increase in the necrosis area seen in the tumor’s central region, as in other experimental groups, including tumor and Dox treated groups, but also in the tumor’s peripheral region. Further, PDT showed minimal adverse effects. Indeed, the use of ZnPcS4-AN in mediating PDT revealed anti-neoplastic activity similar to that obtained while using intratumoral Dox therapy.ConclusionsPDT mediated by the new formulation ZnPcS4-AN enhanced the inhibition of tumor growth while producing practically no adverse effects and thus emerges as a very promising nanotechnology-based strategy for solid cancer treatment.

Experimental Study of the Neurotoxic Effects of Photodynamic Therapy on the Spinal Cord

“…Photodynamic therapy (PDT) is a promising treatment for cancer and non-oncological diseases. [1][2][3][4] It combines a photosensitizer drug (PS, organic dye) with visible light irradiation in the range of the electromagnetic spectrum of appropriate wavelength, and oxygen, each of which alone is harmless. The photodynamic effect produces reactive oxygen species (ROS), which function as lethal cytotoxic agents that inactivate tumor cells, bacteria and other living species.…”

Photodynamic therapy and nuclear imaging activities of zinc phthalocyanine‐integrated TiO2 nanoparticles in breast and cervical tumors

“…The fact that these methods have many side‐effects which has led to the search for more effective and less side‐effect treatments. Among these new therapies, photodynamic therapy (PDT) is known to be the most promising treatment method for cancer treatment and has the least side‐effect …”

Targeted photo-chemo therapy of malignancy on the chest wall while cardiopulmonary avoidance based on Fe3O4@ZnO nanocomposites

“…With ultraviolet (UV) illumination, ZnO nanomaterials can generate cytotoxic reactive oxygen species (ROS) to kill tumor cells. Usually, the limitation of PDT to superficial malignant neoplasm is considered as its shortcoming since the UV light cannot penetrate deeply into human tissues [9–13]. However, just as fire is a good servant but a bad master, it is precisely the point of interest in the study.…”